Inimmune
MT - MissoulaBiotechnology
Focus: Inimmune is an early-stage immunotherapeutics biotechnology company founded in 2024, headquartered in Missoula, MT with a micro-team of 1-50 employees. The company is pre-revenue with two Phase 1 programs targeting oncology and allergic rhinitis.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
Employees
1-50
Open Jobs
0
About Inimmune
AI assessmentNot HiringNo open roles listed right now. Follow Inimmune to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
2 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
Phase 1
Clinical Trials (1)
NCT06038279Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.
Phase 1Help build intelligence for Inimmune
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.